Allogeneic HSCT after PD-1 therapy safe, effective in Hodgkin lymphoma

ASH 2019: Study investigated the efficacy of allogeneic stem cell transplants following treatment with PD-1 inhibitors in relapsed Hodgkin lymphoma.